..., while improving standard of care and quality of life for the patients. Estimated cost savings can reach 275M Euros for each 1M biopsies. The project will implement an open label, single arm, multi-centre, prospective, cohort validation study, performed at 3 sites in Europe, Israel and the USA, supporting the adoption by the medical community and the filing of CE and FDA certification applicatio ...